Examkin

Soru

Zorluk: KolayGastroenterology and Hepatology

During clinical rounds on the internal medicine service, an attending physician is reviewing guideline-directed therapies for Clostridioides difficile with the medical team. Based on current consensus guidelines, correctly pair each patient presentation with the most appropriate therapeutic management strategy.

  • Asymptomatic colonization incidentally discovered on a routine stool PCR screeningObservation and contact precautions without targeted antimicrobial therapy
  • Initial episode of non-severe infection with watery diarrhea and mild leukocytosisInitiation of a standard 10-day oral fidaxomicin or enteral vancomycin regimen
  • First recurrence of infection following an initial standard course of targeted therapyAdministration of a prolonged, tapered-and-pulsed enteral vancomycin schedule
  • Fulminant colitis presenting with hypotension, ileus, and toxic megacolonCombination therapy with high-dose enteral vancomycin and systemic intravenous metronidazole

Cevap

The correct pairings match asymptomatic colonization to observation without antimicrobials; the initial non-severe episode to a standard 10-day oral fidaxomicin or enteral vancomycin regimen; the first recurrence to a prolonged, tapered-and-pulsed enteral vancomycin schedule; and fulminant colitis to combination therapy with high-dose enteral vancomycin and systemic intravenous metronidazole.
Clinical guidelines dictate varying intensities of treatment for Clostridioides difficile depending on the presentation. Asymptomatic carriage warrants no treatment. Initial non-severe episodes are treated with 10 days of fidaxomicin or enteral vancomycin. First recurrences require a strategic tapered-and-pulsed dosing schedule to eradicate germinating spores. Finally, fulminant cases complicated by shock or an ileus necessitate maximal coverage with both high-dose enteral vancomycin and intravenous metronidazole to ensure drug delivery despite poor gut motility.

Adım Adım Çözüm

1
Identify the clinical status of the patient with asymptomatic colonization.
Matches to observation and contact precautions.
Treating asymptomatic carriers does not improve outcomes and violates antibiotic stewardship principles.
2
Determine the severity and history of the initial non-severe infection.
Matches to a standard 10-day regimen of fidaxomicin or enteral vancomycin.
This is the current first-line guideline recommendation for treating an initial episode.
3
Evaluate the patient experiencing a first recurrence.
Matches to a prolonged, tapered-and-pulsed vancomycin schedule.
A tapered pulse allows for the eradication of newly germinated vegetative cells while giving the normal microbiome time to reestablish itself.
4
Assess the critical presentation of fulminant colitis with an ileus.
Matches to combination therapy with enteral vancomycin and intravenous metronidazole.
An ileus prevents oral medications from reliably reaching the colon, making intravenous metronidazole necessary to supplement enteral therapy.

Anahtar Kavram

Guideline-directed management of Clostridioides difficile based on disease severity and recurrence status.
Tahmini Süre:1m 0s
Bu soruyu puanla

Konular

Gastroenterology and Hepatology

Bu konudan daha fazla soru